$93.83
▲ +$2.68
(+2.94%)
Vol 1.7M
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$13.2B
ROE
-246.6%
Margin
-44.2%
D/E
1677.94
Beta
1.67
52W
$30–$112
Wall Street Consensus
34 analysts · Apr 202614
Strong Buy
16
Buy
4
Hold
0
Sell
0
Strong Sell
88.2%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 0.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.72 | $-1.00 | $-0.28 |
| Sep 2025 | $-0.72 | $-0.74 | $-0.02 |
| Jun 2025 | $-0.79 | $-0.80 | $-0.01 |
| Mar 2025 | $-0.82 | $-0.82 | $0.00 |
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Revenue | $201.8M | $203.5M | $232.1M | $265.2M | $281.3M |
| Net Income | -$111.0M | -$95.2M | -$99.9M | -$92.7M | -$128.5M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -246.6% | -246.6% | -246.6% | -246.6% | -246.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -43.0% | -49.9% | -49.9% | -49.9% | -44.2% | -44.2% |
| Gross Margin | 65.0% | 62.8% | 62.8% | 62.8% | 63.8% | 63.8% |
| D/E Ratio | — | 1677.94 | 1677.94 | 1677.94 | 1677.94 | 1677.94 |
| Current Ratio | 3.71 | 3.71 | 3.71 | 3.71 | 3.50 | 3.50 |
Key Ratios
ROA (TTM)
-29.3%
P/S (TTM)
14.64
P/B
20.7
EPS (TTM)
$-3.21
CF/Share
$-3.61
Rev Growth 3Y
+25.5%
52W High
$112.43
52W Low
$29.91
$29.91
52-Week Range
$112.43
Financial Health
Free Cash Flow
-$54.2M
Net Debt
$1.3B
Cash
$378.2M
Total Debt
$1.7B
As of Dec 31, 2025
How does GH compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
GH valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
14.6
▲
467%
above
peers
(2.6)
vs Peers
vs Industry
Overvalued
P/B ratio
20.7
▲
644%
above
peers
(2.8)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
GH profitability vs Health Care peers
ROE
-246.6%
▼
540%
below
peers
(-38.5%)
vs Peers
vs Industry
Weak
Net margin
-44.2%
▼
79%
below
peers
(-24.7%)
vs Peers
vs Industry
Weak
Gross margin
63.8%
▲
20%
above
peers
(52.9%)
vs Peers
vs Industry
Below avg
ROA
-29.3%
▼
38%
below
peers
(-21.2%)
vs Peers
vs Industry
Below avg
GH financial health vs Health Care peers
D/E ratio
1677.9
▲
8603%
above
peers
(19.3)
vs Peers
vs Industry
High debt
Current ratio
3.5
▲
62%
above
peers
(2.2)
vs Peers
vs Industry
Below avg
Beta
1.7
▲
59%
above
peers
(1.1)
vs Peers
vs Industry
More volatile
GH fundamentals radar
GH
Peer median
Industry
GH profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio